Adrienne L. Racanelli
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Protease and Inhibitor Mechanisms, Platelet Disorders and Treatments, Cell Adhesion Molecules Research, Antiplatelet Therapy and Cardiovascular Diseases
Most-Cited Works
- → Discovery of an Orally Active Series of Isoxazoline Glycoprotein IIb/IIIa Antagonists(1997)66 cited
- → Synthesis and pharmacology of modified amidine isoxazoline glycoprotein IIb/IIIa receptor antagonists(2001)60 cited
- → ?v?3, ?v?5, and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formation(1999)47 cited
- → ANTITHROMBOTIC ACTIONS OF SELECTIVE INHIBITORS OF BLOOD COAGULATION FACTOR Xa IN RAT MODELS OF THROMBOSIS(1996)41 cited
- → Mathematical Model of Serine Protease Inhibition in the Tissue Factor Pathway to Thrombin(1995)36 cited
- → Orally Active Isoxazoline Glycoprotein IIb/IIIa Antagonists with Extended Duration of Action(1999)35 cited
- → Recombinant plasminogen activator inhibitor type 1(1994)23 cited
- → αvβ3, αvβ5, and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formation(1999)22 cited
- → Oral Antiplatelet Efficacy and Specificity of a Novel Nonpeptide Platelet GPIIb/IIIa Receptor Antagonist, DMP 802(1998)13 cited
- → Comparison of Recombinant Plasminogen Activator Inhibitor-1 and Epsilon Amino Caproic Acid in a Hemorrhagic Rabbit Model(1992)10 cited